- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07659990
RISS Versus SPSIP Block in Modified Radical Mastectomy (RSMRM)
Comparison of Rhomboid Intercostal-Subserratus Plane Block and Serratus Posterior Superior Intercostal Plane Block for Postoperative Analgesia and Dermatomal Spread After Modified Radical Mastectomy: A Randomized Double-Blind Trial
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
Breast cancer surgery is frequently associated with moderate to severe postoperative pain, which may negatively affect recovery and increase opioid consumption. Ultrasound-guided fascial plane blocks have become an important component of multimodal analgesia strategies for breast surgery.
The rhomboid intercostal-subserratus plane (RISS) block and serratus posterior superior intercostal plane (SPSIP) block are recently described regional anesthesia techniques that may provide effective postoperative analgesia by blocking the lateral and posterior branches of the thoracic spinal nerves. However, comparative clinical evidence regarding their analgesic efficacy and dermatomal coverage in modified radical mastectomy remains limited.
This prospective randomized double-blind controlled trial will compare RISS block and SPSIP block in adult patients undergoing modified radical mastectomy under general anesthesia. Participants will be randomly allocated to receive either RISS block or SPSIP block before surgery. The primary objective is to compare postoperative opioid consumption. Secondary outcomes include postoperative pain scores, dermatomal sensory spread, time to first rescue analgesia, quality of recovery, opioid-related adverse events, and block-related complications.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Yusuf Alan, MD
- Telefoonnummer: +905396210977
- E-mail: dryusufalan@gmail.com
Studie Locaties
-
-
Nilüfer
-
Bursa, Nilüfer, Turkije (Türkiye), 16100
- Werving
- Bursa City Hospital
-
Contact:
- Yusuf Alan, MD
- Telefoonnummer: 05396210977
- E-mail: dryusufalan@gmail.com
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Female patients aged 18-75 years
- ASA physical status I-III
- Scheduled for elective unilateral modified radical mastectomy with axillary dissection under general anesthesia
- Provision of written informed consent
Exclusion Criteria:
- Anticoagulant therapy
- Bleeding diathesis
- Known allergy to local anesthetics or opioids
- Infection at the block application site or previous surgery in the block area
- Cognitive impairment preventing NRS assessment
- Pregnancy or lactation
- Chronic opioid use
- Severe hepatic or renal failure
- Refusal to participate in the study
- Technical inability to perform the block or failed block
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Verdrievoudigen
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: RISS Block
Patients will receive an ultrasound-guided rhomboid intercostal-subserratus plane (RISS) block before modified radical mastectomy for postoperative analgesia.
|
Ultrasound-guided rhomboid intercostal-subserratus plane block performed before modified radical mastectomy for postoperative analgesia.
|
|
Experimenteel: SPSIP Block
Patients will receive an ultrasound-guided serratus posterior superior intercostal plane (SPSIP) block before modified radical mastectomy for postoperative analgesia.
|
Ultrasound-guided serratus posterior superior intercostal plane block performed before modified radical mastectomy for postoperative analgesia.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Total Postoperative Opioid Consumption
Tijdsspanne: 24 hours after surgery
|
Total opioid consumption during the first 24 hours after modified radical mastectomy.
|
24 hours after surgery
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Intraoperative Remifentanil Consumption
Tijdsspanne: During surgery
|
Total intraoperative remifentanil consumption will be recorded and compared between groups.
|
During surgery
|
|
Postoperative Pain Scores
Tijdsspanne: 0-24 hours after surgery
|
Postoperative pain intensity measured using the Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
Higher scores indicate worse pain.
|
0-24 hours after surgery
|
|
Compartmental Pain Scores Using Numeric Rating Scale
Tijdsspanne: 0-24 hours after surgery
|
Numeric Rating Scale (NRS) score (0-10 points) measured separately for axillary pain, anterolateral chest wall pain, and surgical drain insertion site pain.
A score of 0 indicates no pain and 10 indicates the worst imaginable pain.
Higher scores indicate greater pain intensity.
|
0-24 hours after surgery
|
|
Dermatomal Sensory Block Distribution
Tijdsspanne: 30 minutes after block performance
|
Number of dermatomes blocked, assessed by pinprick sensory testing 30 minutes after block performance.
Higher values indicate wider sensory block distribution.
|
30 minutes after block performance
|
|
Quality of Recovery-15 Score
Tijdsspanne: 24 hours after surgery
|
Quality of Recovery-15 (QoR-15) questionnaire score ranging from 0 to 150, where higher scores indicate better postoperative recovery and patient satisfaction.
|
24 hours after surgery
|
|
Block- and Opioid-Related Complications
Tijdsspanne: 24 hours after surgery
|
Complications related to block performance and opioid use will be recorded.
|
24 hours after surgery
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Mürsel Ekinci, MD, Bursa City Hospital
- Studie stoel: Yusuf Alan, MD, Bursa City Hospital
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- MRM-2025-KAEK47
- 2025-KAEK-47 (Andere identificatie: Clinical Research Ethics Committee of University of Health Sciences Bursa Faculty of Medicine)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .